Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1-2 Master Protocol to Study Intravenous ATTR-01 in Adult Participants With Select Epithelial Solid Tumours Under Multiple Sub-protocols

NCT06977737 is registered in ClinicalTrials.gov with Accession Therapeutics Limited as lead sponsor.

NCT NCT06977737
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06977737 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1-2 Master Protocol to Study Intravenous ATTR-01 in Adult Participants With Select Epithelial Solid Tumours Under Multiple Sub-protocols
Lead sponsor
Accession Therapeutics Limited
Phase
Phase 1/2
Overall status
Recruiting
Start date
March 21, 2025
Completion date
December 31, 2034
Enrollment
72 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

solid tumor, adult